Clinical Trial Update: Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in recruiting evaluating platinum- and taxane-based chemotherapy for metastatic castration-resistant prostate cancer with alterations i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• Taxane-based chemotherapy

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer | Phase 3 | Status: RECRUITING